Hospital
Ihc Health Services, INC.
Ihc Health Services, INC. was paid $20.40M by Medicaid between Jan 2018 and Nov 2024, across 193 billing codes. Its largest line is 8888888, Internal/system code - not a standard HCPCS code — 72% of everything it billed.
33Billing provider infoIHC HEALTH SERVICES, INC.
CEDAR CITY, UT 84721
CEDAR CITY, UT 84721
33aNPI1538178801assigned 08/05/2006
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$20.40M
24GClaims325,475
24DCodes billed193
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Medicare Defined Swing Bed Hospital Unit providers in Utah
Rank by total paid#1 of 7
Median peer was paid$524K
This provider vs. median39×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SMITH, DENIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 52,601 | $2.89M | |
| 2019 | 55,505 | $2.79M | |
| 2020 | 60,997 | $3.82M | |
| 2021 | 75,084 | $5.43M | |
| 2022 | 67,018 | $4.75M | |
| 2023 | 9,543 | $485K | |
| 2024incomplete | 4,727 | $225K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 8888888 | Internal/system code - not a standard HCPCS code | 72% | 33,841 | 16,251 | $14.64M |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.1% | 23,598 | 18,702 | $632K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 2.4% | 12,212 | 10,852 | $490K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.3% | 2,956 | 2,241 | $461K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 1.9% | 11,288 | 9,792 | $395K |
| 80050 | General health panel | 1.8% | 3,573 | 3,320 | $358K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.3% | 2,072 | 1,917 | $274K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.3% | 9,437 | 7,512 | $269K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.1% | 4,197 | 3,807 | $225K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,963 | 1,876 | $134K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 813 | 745 | $118K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 537 | 504 | $116K |
181 more codes
| 80081 | <1% | 1,056 | $109K | |
| 85027 | <1% | 2,885 | $94K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,347 | $89K |
| 99285 | Emergency room visit (most serious) | <1% | 5,553 | $78K |
| 71045 | Radiologic examination, chest; single view | <1% | 4,676 | $73K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,720 | $68K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,966 | $67K |
| 81001 | <1% | 11,842 | $63K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,692 | $60K |
| 80053 | Comprehensive metabolic panel | <1% | 21,566 | $51K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,678 | $47K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 556 | $45K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 2,723 | $45K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,384 | $45K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 829 | $37K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,915 | $36K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,018 | $36K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 5,819 | $36K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,405 | $35K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 481 | $34K |
| 81025 | <1% | 1,035 | $34K | |
| 87186 | <1% | 1,650 | $33K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 399 | $33K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 732 | $33K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 184 | $32K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 2,663 | $32K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 165 | $29K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 342 | $29K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 8,621 | $28K |
| 72100 | <1% | 486 | $28K | |
| 73562 | <1% | 593 | $27K | |
| 97602 | <1% | 605 | $26K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,769 | $26K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 406 | $25K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,325 | $25K |
| 87081 | <1% | 1,633 | $23K | |
| 80306 | <1% | 567 | $23K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 516 | $23K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 3,620 | $22K |
| 72141 | <1% | 179 | $21K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,844 | $21K |
| 73110 | <1% | 238 | $20K | |
| J2704 | Injection, propofol, 10 mg | <1% | 3,693 | $19K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 320 | $18K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 2,159 | $18K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,033 | $18K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,941 | $18K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,586 | $18K |
| 73630 | <1% | 299 | $17K | |
| 73610 | <1% | 367 | $17K | |
| 80061 | Lipid panel | <1% | 3,511 | $17K |
| 73030 | <1% | 323 | $16K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,660 | $15K |
| 84702 | <1% | 2,001 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,504 | $14K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,228 | $13K |
| 87631 | <1% | 238 | $13K | |
| 72110 | <1% | 168 | $13K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,977 | $12K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,466 | $12K |
| 84481 | <1% | 1,290 | $11K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 254 | $11K |
| 82247 | <1% | 1,610 | $10K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,260 | $10K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 280 | $9K |
| 84439 | <1% | 2,621 | $9K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 68 | $9K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,289 | $8K |
| 86901 | <1% | 521 | $8K | |
| 84484 | <1% | 3,162 | $8K | |
| 85379 | <1% | 2,015 | $8K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 333 | $7K |
| 83880 | <1% | 1,640 | $7K | |
| 73130 | <1% | 89 | $6K | |
| 93971 | <1% | 195 | $6K | |
| 74018 | <1% | 119 | $6K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,595 | $6K |
| 94729 | <1% | 60 | $5K | |
| 85610 | <1% | 2,644 | $5K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 95 | $5K |
| J3490 | Unclassified drugs | <1% | 124 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 266 | $5K |
| 84703 | <1% | 1,883 | $5K | |
| 82950 | <1% | 1,002 | $4K | |
| 97597 | <1% | 106 | $4K | |
| 76642 | <1% | 132 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 375 | $4K |
| 84403 | <1% | 337 | $3K | |
| 73502 | <1% | 78 | $3K | |
| 84466 | <1% | 1,046 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,582 | $3K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 551 | $3K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 100 | $3K |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 946 | $3K |
| 86003 | <1% | 116 | $3K | |
| 83605 | <1% | 3,698 | $3K | |
| 83690 | <1% | 4,248 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 18 | $2K |
| 76536 | <1% | 26 | $2K | |
| 82607 | <1% | 2,093 | $2K | |
| 82728 | <1% | 1,112 | $2K | |
| 87077 | <1% | 116 | $2K | |
| 83735 | <1% | 2,513 | $2K | |
| 82570 | <1% | 1,029 | $2K | |
| 72040 | <1% | 41 | $2K | |
| 94060 | <1% | 55 | $2K | |
| 96376 | <1% | 1,024 | $2K | |
| 70486 | <1% | 14 | $2K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 803 | $2K |
| 82565 | <1% | 254 | $1K | |
| 86140 | <1% | 2,434 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 337 | $1K |
| 76801 | <1% | 77 | $1K | |
| 83516 | <1% | 65 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 16 | $1K |
| 87088 | <1% | 1,555 | $1K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 31 | $1K |
| 87070 | <1% | 109 | $1K | |
| 85730 | <1% | 779 | $972.48 | |
| 82805 | <1% | 103 | $969.51 | |
| 86900 | <1% | 339 | $944.29 | |
| 72050 | <1% | 14 | $936.13 | |
| 82784 | <1% | 115 | $908.68 | |
| 85651 | <1% | 1,824 | $874.54 | |
| 84550 | <1% | 263 | $859.03 | |
| 82105 | <1% | 16 | $819.34 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 133 | $800.68 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 12 | $799.86 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 258 | $766.86 |
| 73080 | <1% | 13 | $761.98 | |
| 86038 | <1% | 161 | $754.62 | |
| 80069 | <1% | 68 | $703.56 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 934 | $692.09 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 172 | $655.17 |
| 86850 | <1% | 208 | $649.35 | |
| 83540 | <1% | 1,186 | $626.28 | |
| 0450 | Emergency room services | <1% | 16 | $599.74 |
| 86803 | <1% | 273 | $570.68 | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 16 | $453.97 |
| 83970 | <1% | 119 | $422.52 | |
| 80074 | <1% | 27 | $402.75 | |
| 82746 | <1% | 149 | $386.50 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 475 | $369.69 |
| 82947 | <1% | 155 | $342.55 | |
| 80076 | <1% | 41 | $308.34 | |
| 84460 | <1% | 16 | $236.95 | |
| 84100 | <1% | 206 | $220.18 | |
| 82043 | <1% | 403 | $202.91 | |
| 84478 | <1% | 103 | $171.66 | |
| 86431 | <1% | 25 | $162.81 | |
| 86376 | <1% | 96 | $160.82 | |
| 87040 | <1% | 460 | $154.37 | |
| 84153 | <1% | 40 | $136.98 | |
| 84156 | <1% | 132 | $127.14 | |
| 84144 | <1% | 18 | $119.35 | |
| 83001 | <1% | 15 | $90.83 | |
| 82670 | <1% | 25 | $63.23 | |
| 82140 | <1% | 13 | $55.93 | |
| 83615 | <1% | 308 | $52.32 | |
| 82150 | <1% | 753 | $47.91 | |
| 88302 | <1% | 16 | $41.66 | |
| 86800 | <1% | 16 | $28.43 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 89 | $25.43 |
| 86592 | <1% | 28 | $24.35 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 162 | $15.68 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 155 | $4.01 |
| 85007 | 0% | 33 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 44 | $0.00 |
| 90715 | 0% | 53 | $0.00 | |
| 86677 | 0% | 13 | $0.00 | |
| 29125 | 0% | 12 | $0.00 | |
| 94726 | 0% | 14 | $0.00 | |
| 86336 | 0% | 14 | $0.00 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 70 | $0.00 |
| 86780 | 0% | 77 | $0.00 | |
| 84270 | 0% | 13 | $0.00 | |
| G0378 | Hospital observation service, per hour | 0% | 16 | $0.00 |
| 85018 | 0% | 17 | $0.00 | |
| 82677 | 0% | 14 | $0.00 | |
| 90686 | 0% | 17 | $0.00 | |
| 41899 | Unlisted procedure, dentoalveolar structures | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, DENIS (CFO)
| Provider | Location | Paid |
|---|---|---|
| Ihc Health Services, INC. | Murray, UT | $68.77M |
| Ihc Health Services, INC. | St George, UT | $65.78M |
| Ihc Health Services INC | Ogden, UT | $54.08M |
| Ihc Health Services, INC. | Provo, UT | $44.35M |
| Ihc Health Services INC | Logan, UT | $25.34M |
| Ihc Health Services, INC. | Salt Lake City, UT | $19.91M |
| Ihc Health Services, INC. | American Fork, UT | $17.19M |
| Ihc Health Services INC | Riverton, UT | $15.31M |
| Ihc Health Services INC | Sandy, UT | $11.66M |
| Ihc Health Services, INC. | Layton, UT | $11.61M |
| Ihc Health Services, INC. | Burley, ID | $5.14M |
| Ihc Health Services INC | Murray, UT | $4.64M |
| Ihc Health Services INC | St George, UT | $4.35M |
| Ihc Health Services INC | Heber City, UT | $4.31M |
| Ihc Health Services, INC. | Orem, UT | $4.18M |
| Ihc Health Services, INC. | Richfield, UT | $3.87M |
| Ihc Health Services INC | Tremonton, UT | $3.55M |
| Ihc Health Services, INC. | Spanish Fork, UT | $3.49M |
| Ihc Health Services INC | Park City, UT | $2.53M |
| Ihc Health Services, INC. | Mt Pleasant, UT | $2.34M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.